Olr463 inhibitors represent a specialized class of chemical compounds that interact with the Olr463 receptor, a protein that is part of the olfactory receptor (OR) family. These receptors are G-protein coupled receptors (GPCRs) predominantly expressed in the olfactory epithelium, where they play a critical role in the detection of volatile odorant molecules. The Olr463 receptor, specifically, is one among many ORs that bind to specific odorant ligands, initiating a signal transduction pathway that ultimately leads to the perception of smell. The inhibition of Olr463 can thus be understood as a mechanism that potentially modulates the activity of this receptor, altering the binding affinity or the signal transduction efficiency, which may affect the overall sensory processing associated with the detection of particular odorants.
In terms of chemical properties, Olr463 inhibitors may exhibit diverse structural characteristics tailored to interact with the receptor's binding site. These compounds often possess a combination of hydrophobic and hydrophilic regions, facilitating interactions with the receptor's extracellular and transmembrane domains. The binding may involve various non-covalent interactions such as hydrogen bonding, van der Waals forces, and π-π interactions, which contribute to the stability of the inhibitor-receptor complex. The design and synthesis of Olr463 inhibitors often involve structure-activity relationship (SAR) studies, where the chemical structure is systematically modified to enhance receptor binding specificity and efficacy. These inhibitors can be characterized through various analytical techniques, such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling, which provide insights into the molecular interactions and conformational changes induced by the binding of the inhibitor to the Olr463 receptor.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Influences sirtuin pathways, potentially affecting proteins associated with cellular aging and stress response. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum kinase inhibitor, potentially affecting various proteins involved in signaling pathways. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Modulates estrogen receptors, potentially influencing proteins associated with hormone signaling pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylases, potentially affecting gene expression and proteins involved in chromatin remodeling. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Inhibits BMP signaling, potentially affecting proteins involved in developmental pathways. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BET bromodomain proteins, potentially influencing gene expression and associated protein functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, potentially altering proteins involved in the AKT signaling pathway. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates ubiquitin ligase activity, potentially affecting protein degradation pathways. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
Inhibits Aurora kinases, potentially affecting proteins involved in mitotic processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, potentially influencing proteins in cell growth and proliferation pathways. | ||||||